Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Net Margin % : 26.15% (As of Jun. 2024)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Net Margin % Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Net Margin %		Get a 7-Day Free Trial					22.09	19.75	18.71	13.38	12.77

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Margin %	Get a 7-Day Free Trial															11.59	13.12	1.59	26.15	11.37

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin % falls into.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co  (HKSE:01349) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Business Description